Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
4 Results Found
DEA, HHS delay implementation of buprenorphine final rule until Dec. 31
The Drug Enforcement Administration and Department of Health and Human Services yesterday announced that the effective date for the final rule regarding telemedicine prescribing of buprenorphine will be further delayed from March 21 to Dec. 31.
AHA comments on DEA proposed rule on special registrations for telemedicine prescribing
The AHA March 18 commented on the Drug Enforcement Administration's proposed rule for special registrations for telemedicine prescribing of controlled substances.
AHA podcast: Bridging Distances with AI and Telemedicine
In this conversation, Dave Newman, M.D., vice president and chief medical officer for virtual care at Sanford Health, discusses how innovative virtual care models and artificial intelligence-powered solutions are breaking down barriers, improving patient outcomes and enhancing provider efficiency.
HHS, DEA release rules related to telemedicine prescribing of controlled substances
The Department of Health and Human Services and Drug Enforcement Administration published a series of rules Jan. 15 related to telemedicine prescribing of controlled substances, including a special registration proposed rule and a final rule on telemedicine prescribing of buprenorphine.